Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dalcetrapib (JTT-302) Extension Study in Low HDL-C
NCT00748852Phase 2Completed
- Sponsor
- Akros Pharma Inc.
- Start
- Jan 2007
- Primary completion
- Mar 2008
- Countries
- 1
01
Overview
A Phase 2 trial of dalcetrapib in dyslipidemia, sponsored by Akros Pharma Inc.. Started Jan 2007; status: completed.
02
Drugs
dalcetrapib
03
Conditions
dyslipidemia
Beyond the preview
Go deeper on NCT00748852.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00748852.